Severe Heart Failure Case Study: LVEF Increased from 15% to 55% Over 7 Months

Case Overview Mr. Vasudevan Nair, a 74-year-old retired resident of Pune, visited Madhavbaug Ambegaon Budruk with severe breathlessness, weakness, constipation, bloating and dependence on wheelchair support. He had Ischemic Heart Disease (IHD) and Congestive Heart Failure (CHF), with a severely reduced Left Ventricular Ejection Fraction (LVEF) of 15%. His symptoms significantly limited mobility and everyday activity. A personalised, physician-supervised care plan combining regular medical review, lifestyle guidance, dietary support, structured wellness therapies and gradual activity progression was initiated. Over approximately seven months, documented improvements were observed in cardiac function, metabolic parameters, exercise capacity and functional independence. 15% → 55% LVEF 7.1% → 5.3% HbA1c 12.90 → 14.78 VO₂ Max 227.44 → 124 mg/dL Total Cholesterol Patient at a Glance Patient Mr. Vasudevan Nair Age and location 74 years, Pune Primary diagnosis Ischemic Heart Disease (IHD) and Congestive Heart Failure (CHF) Main concerns Severe breathlessness, weakness, reduced exercise tolerance, constipation, bloating and wheelchair dependency Care setting Madhavbaug Ambegaon Budruk Duration Approximately 7 months Key documented result LVEF increased from 15% at presentation to 55% at the latest follow-up Current status Improved mobility, reduced breathlessness, better exercise tolerance and ongoing follow-up The Patient Story Before beginning treatment at Madhavbaug, Mr. Nair experienced progressive physical limitations related to his cardiac condition. Breathlessness while walking, severe weakness, constipation, bloating and poor exercise tolerance disrupted his daily routine. His mobility gradually declined to the point that he required wheelchair support. Routine activities became difficult, reducing his independence and confidence. Concerned about his worsening symptoms and quality of life, he visited Madhavbaug Ambegaon Budruk for a structured and supervised cardiovascular care programme. Symptoms and Impact on Daily Life Symptom or limitation Severity or frequency Effect on daily life Breathlessness on exertion Severe and present for several months Difficulty walking even short distances Severe weakness Frequent and limiting Reduced participation in routine activities Wheelchair dependency Required at presentation Needed assistance for mobility Constipation and bloating Persistent at presentation Reduced comfort and affected general well-being Medical History Before Madhavbaug The patient had a confirmed diagnosis of Ischemic Heart Disease and Congestive Heart Failure and had undergone cardiac evaluation and conventional medical management. Despite prior treatment, severe breathlessness, weakness and functional limitations continued. Investigations showed severe left ventricular dysfunction and substantially reduced cardiac pumping efficiency. Elevated HbA1c and an unfavourable lipid profile added to his overall cardiovascular risk. Ongoing medication was reviewed and coordinated according to the treating physician’s advice. Why He Chose Madhavbaug Mr. Nair sought a physician-supervised programme focused on improving cardiovascular health, exercise tolerance, mobility and quality of life. At Madhavbaug Ambegaon Budruk, he received a personalised assessment, regular follow-up and an integrated care plan based on his age, clinical condition and functional capacity. Clinical Assessment and Treatment Goals Mr. Nair presented with advanced Ischemic Heart Disease and Congestive Heart Failure associated with severe left ventricular dysfunction. The major clinical concerns were severe breathlessness, reduced exercise tolerance, mobility limitations, elevated HbA1c and dyslipidaemia. The treatment priorities were to support cardiovascular function, improve functional capacity, optimise metabolic parameters, enhance mobility and improve day-to-day quality of life. Regular monitoring was incorporated throughout the programme to assess symptoms, treatment adherence, cardiac function and exercise capacity. Personalised Care Plan Care component What the plan included Frequency or duration Purpose Clinical assessment and follow-up Regular physician evaluations and review of symptoms and investigations Throughout the programme Monitor progress and modify the plan when required Structured wellness therapies Individualised Panchakarma and supportive therapies prescribed by the treating doctor As advised Support overall wellness as part of the supervised programme Dietary guidance Heart-friendly dietary plan Daily Support cardiovascular and metabolic health Activity and rehabilitation Gradual walking and mobility progression based on tolerance Daily, as advised Improve strength, mobility and exercise tolerance Medicine coordination Review and coordination of ongoing medicines according to the treating physician’s advice Throughout the programme Support continuity of care and adherence The care plan was tailored to the patient’s age, cardiovascular status, symptom burden and limited exercise capacity. Physician supervision, lifestyle guidance, dietary recommendations, structured wellness therapies and gradual activity progression were integrated into one programme. Follow-up investigations, symptom monitoring and functional assessments were used to track progress. The approach emphasised safe, gradual improvement, consistent adherence and continued evaluation rather than a one-size-fits-all treatment pathway. Progress Over Time Time point Symptoms and function Objective findings Clinical approach Start of care Wheelchair dependent, severe breathlessness on exertion, severe weakness, constipation and bloating LVEF 15%, HbA1c 7.1%, VO₂ Max 12.90 Comprehensive assessment and personalised care plan initiated Month 1 Reduced bloating, improved digestion and slightly better energy Clinical improvement noted Treatment sessions, dietary guidance and monitoring continued Month 2 Reduced breathlessness during routine activity and improved comfort Functional improvement observed Current protocol continued with symptom reassessment Month 3 Improved walking tolerance and reduced dependence on support Better functional capacity Gradual increase in physical activity encouraged Latest follow-up Improved mobility, reduced breathlessness and better quality of life LVEF 55%, HbA1c 5.3%, VO₂ Max 14.78, BP 123/74 mmHg Maintenance plan and periodic cardiac monitoring continued Before-and-After Results Parameter At presentation Latest follow-up Clinical interpretation Left Ventricular Ejection Fraction (LVEF) 15% 55% Documented improvement in cardiac pumping function HbA1c 7.1% 5.3% Improved long-term blood glucose control VO₂ Max 12.90 14.78 Improved exercise capacity and cardiovascular fitness Total Cholesterol 227.44 mg/dL 124 mg/dL Improved lipid profile Blood Pressure Monitored during care 123/74 mmHg Within an acceptable range at the latest follow-up What the Results Meant for the Patient One of the most notable documented findings was the increase in LVEF from 15% to 55%. Improvements were also recorded in HbA1c, VO₂ Max and total cholesterol. Alongside these objective changes, Mr. Nair reported less breathlessness, better mobility, greater stamina and increased confidence while completing daily activities. His body weight remained stable at approximately 51 kg. Continued follow-up and monitoring remain important because this is an individual case and the same outcome cannot be assumed for every patient. Changes in Everyday Life Mr. Nair reported meaningful improvements in mobility and independence. Activities that had previously required assistance